chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had written their birthdate and that they were 18 years old on their form. When entering into database, patient was found (same address/phone number) with a different birthdate. Their system profile stated that they were 17 not 18. Vaccination was given based on their form, stating that they were 18.
Sleepy for one day after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy for one day after receiving the vaccine) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Sep-2021, the patient experienced SOMNOLENCE (Sleepy for one day after receiving the vaccine). In September 2021, SOMNOLENCE (Sleepy for one day after receiving the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The  concomitant medications on use were not provided. No treatment information was provided.
little pain between shoulder blades; eyes are a little baggy; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number EL, it is 0 or an O, 142 and Expiration Date unknown) via an unspecified route of administration on 22Jan2021 at single dose for COVID-19 immunisation. The patient's medical history included a reaction once to fish, but when tested his allergies, the allergist said patient did not have the allergy. The concomitant medications were not reported. Patient did not have really any strong side effects. He had little pain between shoulder blades a couple hours when stood up a couple hours later on 22Jan2021. And when woke up this morning and that was gone. His eyes are a little baggy in Jan2021 but that was not concern. Patient wanted to know about whether or not there is squalene in the product. The outcome of events was unknown without treatment given.  No follow-up attempts are possible. No further information is expected.
Information has been received from a female consumer who on 22-MAY-2007 was vaccinated with a dose of Zostavax. It was reported that on 29-MAY-2007 the patient developed a "big red lump" on her arm and the lump was noted to be painful. No further information is available.
patient fainted once, got up, had hard time breathing, fainted again second time, got up, reported trouble breathing.    epipen administered after, then remained conscious until EMS came, then EMS took him to hospital.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 08-OCT-2008, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended. Instead, the patient contracted a persistent strain of shingles, or severe herpes zoster. On an unknown date in 2016, the patient was treated by a physician for the onset of a rash, which was diagnosed as herpes zoster, or shingles. On or about 27-JAN-2016, the patient sought subsequent treatment from another physician for the diagnosis of herpes zoster polyneuropathy. As a direct and proximate result of the defective ZOSTAVAX vaccine, the patient suffered and continues to suffer painful and ongoing injuries and damages, and required and continues to require extensive medical care and treatment. As a further proximate result of the ZOSTAVAX, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Offsite nurse vaccinated at a nursing home for flu vaccines. Per nurse, "The owner of the nursing home facility filled out the flu forms prior to our arrival on scene and told us which of his patients required a flu shot." The patient received a flu vaccine previously for this season on 09/28/2021 per record. Therefore, the patient received an extra dose of flu vaccine this 2021-2022 season. Per homebound nurse: the owner of the facilities, was notified on 12/14/2021 and the patient was doing fine. Per  nurse, two attempts were made to speak with the owner of facility, but the owner was uncooperative and dismissive in the procedure to follow up and address the situation.
Information has been received from a physician concerning a 16 month old female patient with no known allergies or medical history who on 5/21/04 was vaccinated IM into the right thigh with a second dose of MMR (lot # 644981/1235M). A first dose of MMR live was given on 1/22/04. On 5/24/04 the patient presented to the physician's office with a 103 degree fever (for 4 days) and an ear infection. The patient was treated with antibiotics. It was unknown if the patient recovered. In follow up information from the physician it was reported that the patient received a fourth dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid (lot # U1301DA) on 5/21/04 IM into the left thigh. It was reported that at the time of vaccination the patient had right otitis media and a fever. A CBC, blood culture, urinalysis and urine culture was done but results were not provided. It was reported that the patient recovered. Additional information is not expected.
TDaP vaccine (not exactly sure of brand name)... healthy at time of vaccine then on the 7th day I had severe shooting pains in the right side of my face (cheek, nose, eye, lip). Dr dx'd with Trigeminal Neuralgia the next day and ordered MRI/MRA which came back stable with no evidence of cause for TN. They have given me several medications which either ranged from not working, making me feel ill and unable to work and one caused me to have a seizure and lose consciousness. It is a daily struggle and escalated 11/30/21. Pain is now spreading to lower cheek, lip, jaw and tongue. Currently taking 1800mg Gabapentin which takes the pain down about 50%  but comes with side effects which make me unable to work (severe fatigue, forgetfulness, unable to problem solve, concentration issues, dizziness, headache and nausea). Currently waiting on consultation for surgical intervention (currently scheduled for 1/22/22).
expired dose of DAPTACEL being administered to a patient with no reported adverse event; Initial information received on 08-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional via call center.  This case involves a 18 months old female patient who was administered expired dose of daptacel with no reported adverse event while receiving vaccine diphtheria-15/tetanus/5 ac pertussis vaccine [Daptacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included polio vaccine inact 3v (vero) (ipol [polio vaccine inact 3v (vero)]); Hepatitis A Vaccine (Hepatitis A); and Pneumococcal Vaccine Conj 13V (CRM197) (Prevnar 13) all for immunization.  On 08-Jun-2022, the patient received a 2nd, 0.5 ml dose of suspect diphtheria-15/tetanus/5 ac pertussis vaccine lot C5732AA, expiry date: 24-Apr-2022 Frequency is once, unknown strength and formulation via intramuscular route in the left thigh as immunization.  On 08-JUN-2022 the patient developed a non-serious event expired dose of daptacel being administered to a patient with no reported adverse event (expired product administered) latency: same day following the administration of diphtheria-15/tetanus/5 ac pertussis vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (expired product administered).  At time of reporting, the outcome was Unknown for the event expired product administered.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Excessive bleeding , related to menstrual cycle.  I have an IUD.  I shouldn't be bleeding at all or I should experience minimal bleeding.  This vaccine bs is out here killing and fucking people up worse than Covid would.
A light pink, smooth rash began on belly  approximately 9 days post vaccination. At approximately 12 days post vaccination, rash began to cover entire body. At 13 days post vaccination, the rash covered entire body, concentrated at the ear lobes, cheeks, and feet. The rash was also raised, similar to hives, and bright red.
Information has been received from a health professional concerning an infant pt who in approximately 1998, was vaccinated with one dose of hep b vaccine recombinant. It was reported that the pt had "inconsolable crying, as a baby, due to hep b vaccine recombinant." Upon follow-up, the registered nurse communicated that "the pt you are referring to was reported 3 years ago." No further info is available.
Had acute onset of right MTP Joint pain with peak at 48 hours and duration of 10 days with swelling pain and loss of flexibility and loss of discoloration. Saw Dr. on 10/11/2022. Diagnosed with Gout. Started me on Medroldose Pack. Before saw Dr had treated it with Nsaids. Had a prior episode 2 years ago with Health visit on other foot was considered Gout, and it resolved quicker and no therapy instituted.
Abdominal pain that I thought was gas, went to ER, and after ultrasound, they discovered it was gallstone. I was there overnight, and around 07:00AM, the pain had passed and they assumed gallstone had passed. They sent me home and pretty much the same thing happening on the night of the 3rd May 2021, same pains. I went to urgent care, and they checked me in and surgically removed the gallbladder which took place on May 4th. I was there for three nights, from Monday and they released me on the 6th. They sent me home with ibuprofen, gabapentin and a stool softener. I stopped using the stool softener after one or two days, and after a couple of days, I stopped taking pain meds as well (both). Follow up phone visits with primary care doctor, 5/11/2021, good recovery was reported and follow up with surgeon, 5/8th.
This spontaneous report was received from the husband of a 79 year old female patient, concerning his wife. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On unknown dates, the patient received 2 injections of PNEUMOVAX 23 in the arm, "9 months apart" at the recommendation of her physician (dose, route of administration, lot number and expiry date were not provided). No adverse event was reported.
25 yo female received first dose of Moderna COVID-19 vaccine on 1/8. Received second dose on 2/5. Patient was COVID positive in November 2020 where she was hospitalized. She has continued to have chest pain, shortness of breath, and syncopal episodes. Patient to return to clinic on 3/23 for scheduled tilt table test. She was instructed to complete COVID testing on 3/18 which resulted positive. She has had lingering cough and SOB since COVID diagnosis in November and denied any fever currently. Nasopharyngeal swab obtained 3/18 at 1445. Coronavirus PCR test resulted positive later that evening. Patient still went into clinic for appointment on 3/23.
At 12:00 noon, started crying, pulling legs up and was unable to console baby. She had a decrease in appetite with swelling to right leg.
Both my wife and I after slight symtoms from the booster as described; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Both my wife and I after slight symtoms from the booster as described) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Both my wife and I after slight symtoms from the booster as described). At the time of the report, VACCINATION COMPLICATION (Both my wife and I after slight symtoms from the booster as described) had resolved. Not Provided          No concomitant medications reported by reporter.  The next day after booster dose, patient received high dose flu shot.   This case was linked to MOD-2021-363423, MOD-2021-363442 (Patient Link).
muscle pain; weakness; fatigue; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a 59-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th January 2020, the patient received the 2nd dose of Shingrix. In January 2020, less than a week after receiving Shingrix, the patient experienced muscle pain, weakness and fatigue. On an unknown date, the outcome of the muscle pain, weakness and fatigue were unknown.   It was unknown if the reporter considered the muscle pain, weakness and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and experiencing common side effects muscle pain, weakness, fatigue.  The reporter asked how long should expect these symptoms.
Debilitating hip pain with numbness in leg. Being treated by internist, orthopedist and cardiologist from adverse reaction due to severe inflammation. Symptoms began shortly after vaccine and aren't improving. I find it difficult to walk and now limp. Under a dr's care trying to correct these issues. This has been a nonstop problem with no relief from symptoms.
Itching under arm and right breast; Pain in shoulder blade; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 08Apr2021 at 13:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 09Apr2021 at 17:00, the patient experienced itching under arm and right breast and pain and shoulder blade. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events itching under arm and right breast and pain in shoulder blade was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Pt had allergic RXN. Left side of face swollen, ears itching, rash on body extensive. Sat. eyes swollen shut, vision blocked. Sun. itching and spreading to back and stomach. Pt went to Dr. 3 days later after trying to self medicate with BENADRYL and hydrocortisone cream. Pt received steroid shot from doc and the RX for steroid pack and ALLEGRA. Pt doing better today 7/20/18.
BRUISING ON LEFT SIDE OF STOMACH, RIGHT SIDE OF CHEST, ON BACK, FOREHEAD ABOVE RIGHT EYE AND ON RIGHT WRIST; CHILLS; ACHY AND SORE TO TOUCH AREAS; NAUSEA; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included cholesterol elevated, overweight, alcohol use, and nonsmoker, and other pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, treatment medications included: ibuprofen. On 08-MAR-2021, the subject experienced achy and sore to touch areas. On 08-MAR-2021, the subject experienced nausea. On 08-MAR-2021 01:00, the subject experienced chills. On 09-MAR-2021, the subject experienced bruising on left side of stomach, right side of chest, on back, forehead above right eye and on right wrist. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 09-MAR-2021, and nausea on 08-MAR-2021, and had not recovered from achy and sore to touch areas, and bruising on left side of stomach, right side of chest, on back, forehead above right eye and on right wrist. This report was non-serious.
Complaints of "nerve" pain down left arm into hand, more heaviness noted in lower arm.
Swollen lymph nodes very close to my right nipple, just above the nipple, with redish color and where I felt itch. That lasted around 2 days with some pain, then disappeared.
Information has been received from a physician concerning a 61 year old female with sulfonamide allergy who on 29-JAN-2009 was vaccinated SC with ZOSTAVAX (Merck) (LOT# 662858/1558X) 0.65ml.  Concomitant therapy included multiple unspecified medications.   On approximately 30-JAN-2009, "after receiving" ZOSTAVAX (Merck), the patient developed light sensitivity and a couple of "sores around her nose".  The patient's light sensitivity and a couple of "sores around her nose" persisted.  The adverse events were considered to be disabling.  It was reported that the patient sought medical attention: phone call.  Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 21-OCT-2015 02:54, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L016427, expiry date: 13-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high temperature and low temperature were 8.5 (47 mins) and -2.7 (13hours 16 mins) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
No adverse event to vaccine.  Contracted Covid - positive home test 12/11/2022.  Body aches, fever, cough, severe nasal congestion
larger than fifty cents red, hot & hard to touch @ inj site; mom said red & hot covered area down to forearm;
Vial was stored in refrigerator on 17-FEB-2022, expired on 01-APR-2022 and administered on 06-APR-2022; Patients administered with expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients administered with expired vaccine) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 17-FEB-2022, expired on 01-APR-2022 and administered on 06-APR-2022) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients administered with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 17-FEB-2022, expired on 01-APR-2022 and administered on 06-APR-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients administered with expired vaccine) and PRODUCT STORAGE ERROR (Vial was stored in refrigerator on 17-FEB-2022, expired on 01-APR-2022 and administered on 06-APR-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported.  Date the vial was initially stored in refrigerator was on 17-Feb-2022 at 10 AM. Vial did not undergo any temperature excursion. Patient did not had adverse events.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Apr-2022: Follow-up contains Non-Significant information
Initial report was received from a healthcare professional on 15 June 2012. A female patient (age and birth date not reported) received an injection of TYPHIM VI, Sanofi Pasteur SA, lot number G0181-1 (route and site not reported) on 08 June 2012. On 10 June 2012 (reported as 11 June 2012 when patient required a doctor visit with her healthcare provider), patient developed tightness in throat and spasm of throat area which would come and go every few seconds, reported as 24 hours of symptoms at doctor visit on 11 June 2012. The patient reported symptoms resolved for the next 36 hours after doctor visit, then symptoms returned and still persisted on 15 June 2012, the date of report. The patient's medical history was not reported. The patient's outcome remained not recovered at time of report. Documents held by sender: None.
Blurry vision, dizziness, nausea. Patient laid flat on gurney and given water. BP: 133/82, then 130/89. Pulse: 89, then 65. O2 sat 99%.
headache; body aches; change in sense of smell; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (body aches) and PAROSMIA (change in sense of smell) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced HEADACHE (headache), MYALGIA (body aches) and PAROSMIA (change in sense of smell). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 12-May-2021, HEADACHE (headache) and MYALGIA (body aches) had resolved. At the time of the report, PAROSMIA (change in sense of smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Twelve hours after injection, I began to have a fever.  Maximum recorded temperature (prior to taking Tylenol) was 103.5 deg. F. The fever lasted about 36 hours.  Injection site became red, hot, and sensitive to the touch, increasing in size and spread.  About two days after the shot, the primary injection site rash measured approx. 8 cm X 10 cm.  A secondary rash below the site measured 3 cm X 5 cm. On 16 April, I iced the primary site, which brought some of the redness down, but did not significantly reduce the sensitivity or heat from the site. Today, 17 April (four days after injection), the redness has spread along my arm, and is still sensitive to the touch and hot.